Reply: a new look at the pathogenesis of Parkinson's disease

Author： Przedborski S.   Vila M.   Jackson-Lewis V.   Dawson T.M.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.21, Iss.5, 2000-05, pp. : 165-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tetrahydropapaveroline in Parkinson's Disease and Alcoholism: A Look Back in Honor of Merton Sandler

By Collins M.A.  

Neurotoxicology, Vol. 25, Iss. 1, 2004-01 ,pp. : 117-120

Elsevier

Access to resources Recommend Favorite

Current Opinions and Perspectives on the Role of Immune System in the Pathogenesis of Parkinson's Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 2, 2012-01 ,pp. : 200-208

Bentham Science Publishers

Access to resources Recommend Favorite

New small molecules for the treatment of Parkinson's disease

By Müller Thomas  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1077-1086

Informa Healthcare

Access to resources Recommend Favorite

New Agents Promote Neuroprotection in Parkinson's Disease Models

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 4, 2012-06 ,pp. : 410-418

Bentham Science Publishers

Access to resources Recommend Favorite

New Molecular Avenues in Parkinson’s Disease Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-07 ,pp. : 913-948

Bentham Science Publishers

Access to resources Recommend Favorite